Company / SG&A per Share
Enveric Biosciences, Inc. SG&A per Share History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$6.38
FY2019
5-year range
$0.67 / $6.38
FY2017-FY2019
Trend
+525.6%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share changed +526% YoY in FY2019, a notable deviation from the 2-year average annual change of +288%.
Based on SEC 10-K filings.
6.38 in FY2019.
Increased from $0.67 to $6.38 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, sg&a per share increased 525.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $6.38 | +525.6% |
| FY2018 | $1.02 | +51.2% |
| FY2017 | $0.67 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026